-- Scott Roberts
TUESDAY, Dec. 21 (HealthDay News) -- Medtronic's Endurant AAA
Stent Graft system, designed to treat a bulge in the largest
abdominal blood vessel, has been approved by the U.S. Food and Drug
Administration, the company said Tuesday.
An aneurysm is a bulging portion of a blood vessel that
threatens to rupture. Some 1.2 million people have an abdominal
aortic aneurysm, which typically causes no symptoms, Medtronic said
in a news release. About 70 percent to 90 percent of such patients
die if the aneurysm ruptures, the company added.
The newly approved device is a flexible wire frame sewn into a
fabric tube. It's implanted in the weakened portion of the aorta,
reducing pressure on the aneurysm and diminishing the risk of
The device is delivered via catheters that are inserted in blood
vessels in the groin, Medtronic said.
National Library of Medicine has more about this
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.